| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.009 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |